Effects of glucagon-like peptide-1 receptor agonists on kidney function and safety in type 2 diabetes patients

被引：4
|
作者：
Kim, Min Kyung [1 ]
Kim, Doo-Man [1 ]
机构：
[1] Hallym Univ, Coll Med, Dept Internal Med, Div Endocrinol,Kangdong Sacred Heart Hosp, Seoul, South Korea
来源：
JOURNAL OF DIABETES INVESTIGATION | 2021年 / 12卷 / 06期
关键词：
D O I：
10.1111/jdi.13552
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Glucagon-like peptide-1 receptor agonists have been recommended in diabetic kidney disease patients.
引用
收藏
页码：914 / 916
页数：3
相关论文
共 50 条
  • [21] Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes
    Dankner, Rachel
    Murad, Havi
    Agay, Nirit
    Olmer, Liraz
    Freedman, Laurence S.
    JAMA NETWORK OPEN, 2024, 7 (01) : E2350408
  • [22] Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists
    Foer, Dinah
    Beeler, Patrick E.
    Cui, Jing
    Karlson, Elizabeth W.
    Bates, David W.
    Cahill, Katherine N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (07) : 831 - 840
  • [23] Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
    Harris, Kira B.
    McCarty, Delilah J.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 3 - 18
  • [24] Potential kidney protective effects of glucagon-like peptide-1 receptor agonists
    Trevella, Philippa
    Ekinci, Elif I.
    Macisaac, Richard J.
    NEPHROLOGY, 2024, 29 (08) : 457 - 469
  • [25] Glucagon-like peptide-1 receptor agonists to treat chronic kidney disease associated with type 2 diabetes
    Khan, Irfan
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2025, 197 (06) : E165 - E166
  • [26] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [27] The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes
    Win L. Yin
    Steve C. Bain
    Thinzar Min
    Diabetes Therapy, 2020, 11 : 835 - 844
  • [28] Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features
    Katherine A. Lyseng-Williamson
    Clinical Drug Investigation, 2019, 39 : 805 - 819
  • [29] Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
    Ahren, Bo
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 196 - 201
  • [30] Glucagon-like Peptide-1 Receptor Agonists Prescribing Patterns in Youth with Type 2 Diabetes
    Bensignor, Megan
    Kelly, Aaron
    Wolfe, Jack
    Rudser, Kyle
    Arslanian, Silva
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 1): : 81 - 82
12345